T1	Condition 0 9	treatment
T2	Condition 30 45	B-cell lymphoma
T3	Negation 10 15	naive
R1	Has_negation Arg1:T1 Arg2:T3	
T4	Condition 47 61	HBsAg positive
T5	Temporal 62 73	at baseline
R2	Has_temporal Arg1:T4 Arg2:T5	
T6	Qualifier 88 103	rituximab-based
T7	Drug 88 97	rituximab
R3	multi Arg1:T6 Arg2:T7	
T8	Procedure 104 122	immunochemotherapy
R4	Has_qualifier Arg1:T8 Arg2:T6	
T9	Observation 124 139	life expectancy
T10	Value 143 161	more than 3 months
R5	Has_value Arg1:T9 Arg2:T10	
